This advert is not available!
Umeå University is one of Sweden’s largest higher education institutions with over 37,000 students and about 4,700 employees. The University offers a diversity of high-quality education and world-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything is close. Our cohesive campuses make it easy to meet, work together and exchange knowledge, which promotes a dynamic and open culture.
The ongoing societal transformation and large green investments in northern Sweden create enormous opportunities and complex challenges. For Umeå University, conducting research about – and in the middle of – a society in transition is key. We also take pride in delivering education to enable regions to expand quickly and sustainably. In fact, the future is made here.
Are you interested in learning more? Read about Umeå university as a workplace
The Faculty of Medicine, which consists of 12 departments, is responsible for biomedical research and courses in the field of nursing and health care and has an extensive research and graduate education in more than 80 subjects.
Research environment
Umeå University is the place where the discovery of CRISPR-Cas9 was discovered, that later received the Nobel prize in chemistry.
The position will be carried out in Dr Fors Connolly´s research group, that is interdisciplinary with clinicians, statisticians, epidemiologists and biomedical researchers. Recently, the research group of Fors Connolly published an epidemiological paper in The Lancet regarding the association between COVID-19 and acute cardiovascular events. The research focus is on determining underlying mechanisms of disease pathogenesis of COVID-19, Hemorrhagic fever with renal syndrome and Influenza. Focus is also on predicting which individuals are at risk of having a severe disease outcome following infection using biobank data. The research in Fors Connolly´s group has a translational focus with large-scale population studies to clinical studies to laboratory studies. The fellow will further work in close collaboration with the group of Dr. Marta Bally (Department of Clinical Microbiology).
At the Dept. of Clinical Microbiology, another research group published a paper in New England Journal of Medicine. There is therefore world-class research being performed both in the group of Fors Connolly but also at the department of Clinical Microbiology, and you are most welcome to join us.
Work assignments
The Department of Clinical Microbiology, Umeå University, is looking for a principal research engineer (research associate) for a 2-year position. The associate will be active in a research project aiming at elucidating the contribution of endothelial cells and specifically endothelial glycocalyx degradation to underlying molecular pathogenesis of diseases caused by viral infections, and at predicting which individuals are at risk of severe outcome.
You will:
Selection criteria
For this employment the specific requirements are:
It is expected that the candidate can conduct research in a highly independent manner. In addition, the candidate should have documented good ability to work in an interdisciplinary environment at the interface between medicine and biology and to cooperate with other research groups.
Application
The application should contain:
Full time position, two years – start according to agreement
The application is made electronically (via the system Varbi). Last day to apply is:22-01-11
For questions, please contact:
Anne-Marie Fors Connolly, Department of Clinical Microbiology, E-mail: anne-marie.fors.connolly@umu.se
We welcome your application!
Type of employment | Temporary position |
---|---|
Contract type | Full time |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Umeå |
County | Västerbottens län |
Country | Sweden |
Reference number | AN 2.2.1-1993-21 |
Contact |
|
Union representative |
|
Published | 21.Dec.2021 |
Last application date | 11.Jan.2022 11:59 PM CET |